For those with a significant personal or family history of breast, ovarian, colon, prostate or pancreatic cancer, a Myriad MyRisk assessment may be appropriate. This is a simple blood draw that screens for BRCA 1 and BRCA 1, the most common genetic mutations we know are linked to breast and ovarian cancer, as well as a plethora of other components in DNA that may increase risk for one of the above mentioned types of cancer. For most patients with a gene-negative result, a risk-score is calculated which determines the likelihood of developing one of these cancers in your lifetime. A score below 20% is considered average risk. If a lifetime risk score exceeds 20%, suggestions are made for increased surveillance, which may include initiating yearly mammograms at a younger age or recommending a contrasted breast MRI annually in hopes of early detection.